Skip to main content
SpringerLink
Log in

ISIS 2302

INXC ICAM1, Oligo-TCS®

  • Adis R&D Profile
  • Published:
Drugs in R & D Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Glover JM, Leeds JM, Mant TGK, et al. Phase I safety and pharmacokinetic profile of an intercellular adhesion molecule-1 antisense oligodeoxynucleotide (ISIS 2302). J Pharmacol Exper Ther 1997 Sep; 282: 1173–80

    CAS  Google Scholar 

  2. Henry SP, Larkin R, Novotny WF, et al. Effects of ISIS 2302, a phosphorothioate oligonucleotide, on in vitro and in vivo coagulation parameters. Pharm Res 1994 Oct; 11 Suppl.: 353

    Google Scholar 

  3. Media Release: Isis Pharmaceuticals, 1996 Jul 15

    Google Scholar 

  4. Lappin J, Podbielski J, Welsh M, et al. A phase I study: the side-effect profile of an intercellular adhesion molecule-1 antisense phosphorothioate oligodeoxynucleotide, ISIS 2302. Transplantation 1998 Jun 27; 65: S63

    Article  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

ISIS 2302. Drugs R&D 1, 85–86 (1999). https://doi.org/10.2165/00126839-199901010-00028

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00126839-199901010-00028

Keywords

Search

Navigation